A Lifelong Commitment
As Cartesian’s founders, we are physician-scientists who have dedicated our careers to treating patients and curing diseases. We founded Cartesian because our own family members were diagnosed with cancer and we wanted to do something about it. We realized that curative therapies were not yet available, so we decided to develop them ourselves. In order to have curative potential, we recognized that therapies had to be potent yet safer. In the process, we realized that we could use these therapies to treat patients with autoimmune diseases as well.
Today, as part of FDA-allowed clinical trials, we are treating patients with autoimmune diseases and cancer. We are grateful to our trial participants for partnering with us to bring these cutting-edge therapies to many more patients.
The below patient advocacy groups are able to provide detailed educational resources and community support to patients and families impacted with myasthenia gravis and multiple myeloma.
The Cartesian team would like to express our heartfelt thanks to patients, families, and healthcare providers who have participated in our clinical studies.